Our previous publications suggested that higher levels of cancer cell proliferation, EMT, and motility [11], as well as the upregulation of TGFβ1 and PI3K/AKT pathways are essential for the development of vessel co-option CRCLM lesion [52,53,54]. This evidence concerns the gene AKT1 and cancer.